Cargando…

Epidermolysis bullosa pruriginosa responding to dupilumab

Detalles Bibliográficos
Autores principales: Clawson, Rebecca C., Duran, Stephan F., Pariser, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427235/
https://www.ncbi.nlm.nih.gov/pubmed/34522751
http://dx.doi.org/10.1016/j.jdcr.2021.07.036
_version_ 1783750152206417920
author Clawson, Rebecca C.
Duran, Stephan F.
Pariser, Robert J.
author_facet Clawson, Rebecca C.
Duran, Stephan F.
Pariser, Robert J.
author_sort Clawson, Rebecca C.
collection PubMed
description
format Online
Article
Text
id pubmed-8427235
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84272352021-09-13 Epidermolysis bullosa pruriginosa responding to dupilumab Clawson, Rebecca C. Duran, Stephan F. Pariser, Robert J. JAAD Case Rep Case Report Elsevier 2021-08-18 /pmc/articles/PMC8427235/ /pubmed/34522751 http://dx.doi.org/10.1016/j.jdcr.2021.07.036 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Clawson, Rebecca C.
Duran, Stephan F.
Pariser, Robert J.
Epidermolysis bullosa pruriginosa responding to dupilumab
title Epidermolysis bullosa pruriginosa responding to dupilumab
title_full Epidermolysis bullosa pruriginosa responding to dupilumab
title_fullStr Epidermolysis bullosa pruriginosa responding to dupilumab
title_full_unstemmed Epidermolysis bullosa pruriginosa responding to dupilumab
title_short Epidermolysis bullosa pruriginosa responding to dupilumab
title_sort epidermolysis bullosa pruriginosa responding to dupilumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427235/
https://www.ncbi.nlm.nih.gov/pubmed/34522751
http://dx.doi.org/10.1016/j.jdcr.2021.07.036
work_keys_str_mv AT clawsonrebeccac epidermolysisbullosapruriginosarespondingtodupilumab
AT duranstephanf epidermolysisbullosapruriginosarespondingtodupilumab
AT pariserrobertj epidermolysisbullosapruriginosarespondingtodupilumab